雜志介紹

Translational Psychiatry雜志介紹

《Translational Psychiatry》是(shi)一本(ben)以English為(wei)(wei)(wei)主(zhu)的(de)(de)開(kai)放獲取國際優秀期刊(kan)，中(zhong)文名稱轉化精神病學(xue)，本(ben)刊(kan)主(zhu)要出版、報道醫學(xue)-PSYCHIATRY領域(yu)(yu)的(de)(de)研(yan)究動態以及在該(gai)(gai)(gai)領域(yu)(yu)取得(de)的(de)(de)各方(fang)面的(de)(de)經(jing)驗和科研(yan)成果，介紹(shao)該(gai)(gai)(gai)領域(yu)(yu)有關本(ben)專(zhuan)業(ye)的(de)(de)最新(xin)進(jin)展，探討(tao)行(xing)業(ye)發展的(de)(de)思路(lu)和方(fang)法，以促進(jin)學(xue)術信(xin)息交流，提高行(xing)業(ye)發展。該(gai)(gai)(gai)刊(kan)已被(bei)國際權(quan)威數(shu)(shu)據庫SCIE收錄，為(wei)(wei)(wei)該(gai)(gai)(gai)領域(yu)(yu)相(xiang)關學(xue)科的(de)(de)發展起到(dao)(dao)了(le)良好的(de)(de)推動作用，也得(de)到(dao)(dao)了(le)本(ben)專(zhuan)業(ye)人員的(de)(de)廣泛認(ren)可。該(gai)(gai)(gai)刊(kan)最新(xin)影響因子為(wei)(wei)(wei)5.8，最新(xin)CiteScore 指數(shu)(shu)為(wei)(wei)(wei)11.5。

本(ben)刊(kan)近期中國學者(zhe)發表的論(lun)文主要有(you)：

• Neuroinflammation mechanisms of neuromodulation therapies for anxiety and depression

  Author: Guo, Bingqi; Zhang, Mengyao; Hao, Wensi; Wang, Yuping; Zhang, Tingting; Liu, Chunyan

• Serum complement proteins rather than inflammatory factors is effective in predicting psychosis in individuals at clinical high risk

  Author: Zhang, TianHong; Zeng, JiaHui; Ye, JiaYi; Gao, YuQing; Hu, YeGang; Xu, LiHua; Wei, YanYan; Tang, XiaoChen; Liu, HaiChun; Chen, Tao; Li, ChunBo; Wan, ChunLing; Wang, JiJun

• Carboxypeptidase E conditional knockout mice exhibit learning and memory deficits and neurodegeneration

  Author: Fan, Fang-Cheng; Du, Yang; Zheng, Wen-Hui; Loh, Y. Peng; Cheng, Yong

• Physical exercise mediates a cortical FMRP-mTOR pathway to improve resilience against chronic stress in adolescent mice

  Author: Yan, Lan; Wang, Mei; Yang, Fengzhen; Wang, Yajie; Wang, Siqi; So, Kwok-Fai; Zhang, Li

英文介紹

Translational Psychiatry雜志英文介紹

Psychiatry has suffered tremendously by the limited translational pipeline. Nobel laureate Julius Axelrod's discovery in 1961 of monoamine reuptake by pre-synaptic neurons still forms the basis of contemporary antidepressant treatment. There is a grievous gap between the explosion of knowledge in neuroscience and conceptually novel treatments for our patients. Translational Psychiatry bridges this gap by fostering and highlighting the pathway from discovery to clinical applications, healthcare and global health. We view translation broadly as the full spectrum of work that marks the pathway from discovery to global health, inclusive. The steps of translation that are within the scope of Translational Psychiatry include (i) fundamental discovery, (ii) bench to bedside, (iii) bedside to clinical applications (clinical trials), (iv) translation to policy and health care guidelines, (v) assessment of health policy and usage, and (vi) global health. All areas of medical research, including — but not restricted to — molecular biology, genetics, pharmacology, imaging and epidemiology are welcome as they contribute to enhance the field of translational psychiatry.